Jerome H. Kim

Dr. Jerome H. Kim is currently the Director General of the International Vaccine Institute, which works to discover, develop and deliver safe effective and affordable vaccines for Global Health. IVI’s oral cholera vaccine, prequalified by Sanofi and EuBiologics, is used around the world to prevent that deadly diarrheal disease.

IVI’s typhoid conjugate vaccine is entering Phase II testing by SK Chemicals and PT Bio Farma. Prior to IVI, Dr. (COL) Kim led the US Army’s advanced development program for HIV vaccines, the RV144 HIV vaccine trial and correlates analysis, and a molecular virology laboratory at Walter Reed Army Institute of Research. He is a graduate with high honors and highest honors in History and Biology, respectively, from the University of Hawaii, and received an MD degree from Yale University School of Medicine.